The Comparison of two approach of drug transition in shoulder impingement patients

Not Applicable

• Conditions: Shoulder Impingement Syndrome.; Impingement syndrome of shoulder; m75.4

• Registration Number: IRCT20161221031506N3
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Pain less than 3 month
Pain in the upper, outer arm especially when lifting of arm
Aged 18-65 years
Signs of shoulder impingement syndrome : Presence of at least two of the following
1) Painful arch movement during flexion or abduction of the shoulder
2) Positive Neer or Hawkins-Kennedy test
3) Painful resisted external rotation, abduction or painful jobe (empty can) test

Exclusion Criteria

Existence of type 3 acromion
Existence of frozen shoulder ( the loss in passive shoulder range of motion greater than 50% as compared to the uninvolved side in at least 2 shoulder movements)
Existence of neck radiculopathy
Existence of Complete rupture of rotator cuff muscles (MRI findings)
Existence of shoulder joint instability (Positive tests of sulcus or apprehension)
Use of corticosteroid drugs in last 3 months
History of RSD
History of any neurological diseases
History of rheumatoid diseases and shoulder osteoarthritis
History of fracture or dislocation or surgery in the shoulder complex

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: visit time- after 10 days placebo intervention- after 10 days treatment period. Method of measurement: visual analog scale.;Disability. Timepoint: visit time- after 10 days placebo intervention- after 10 days treatment period. Method of measurement: by SPADI questionnaire.;Quality of life. Timepoint: visit time- after 10 days placebo intervention- after 10 days treatment period. Method of measurement: by WORC questionnaire.;Treatment effect. Timepoint: discharge time. Method of measurement: by Global Rating Scale.